Insperity(US:NSP) Prnewswireยท2025-08-06 22:40Core Viewpoint - Insperity, Inc. is under investigation for potential securities fraud following a significant decline in its financial performance, which has led to a sharp drop in its stock price [1][2][3]. Financial Performance - Insperity reported adjusted earnings per share of $0.26 for Q2 2025, which was a 70% decline year-over-year and below analyst expectations [2]. - The company attributed its poor performance to higher-than-expected benefits costs, particularly due to rising pharmacy expenses and an increase in large insurance claims [2]. - Following the announcement of these results, Insperity's stock price fell by $14.51, or 24.35%, closing at $45.07 per share on August 1, 2025 [3]. Legal Investigation - Pomerantz LLP is investigating claims on behalf of Insperity investors regarding possible securities fraud or other unlawful business practices by the company and its officers or directors [1].